Literature DB >> 21944821

Comment on: Venous thromboembolism prophylaxis following hip arthroplasty.

D Withers1, C Toolan, M Cope.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21944821      PMCID： PMC3363113          DOI： 10.1308/003588411X572024

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  4 in total

1.  Ninety-day mortality after elective total hip replacement: 1549 patients using aspirin as a thromboprophylactic agent.

Authors:  M Parry; V Wylde; A W Blom
Journal:  J Bone Joint Surg Br       Date:  2008-03

2.  Venous thromboembolic disease after total hip and knee arthroplasty.

Authors:  Steven B Haas; Robert L Barrack; Geoffrey Westrich; Paul F Lachiewicz
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

3.  The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.

Authors:  L A Cusick; D E Beverland
Journal:  J Bone Joint Surg Br       Date:  2009-05

4.  The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb.

Authors:  S S Jameson; A Bottle; A Malviya; S D Muller; M R Reed
Journal:  J Bone Joint Surg Br       Date:  2010-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.